CTS Mobile Testing

06 November 2009 SUCCESSFUL BONE MARROW REGENERATION IN CANCER PATIENTS USING CORD BLOOD EXPANDED BY PROPRIETARY STEM CELLS 25 August 2009 ANGIOBLAST CLOSES $10M EQUITY-BASED FINANCINGANGIOBLAST CLOSES $10M EQUITY-BASED FINANCING Angioblast Systems, Inc ( Angioblast or the Company ) is a privately held biotechnology company formed in 2001. The Company is committed to becoming a world leader in the development and commercialization of novel therapeutic products for the treatment of cardiovascular diseases ( CVD ) and vascular disorders. Angioblast intends to achieve this goal through the advancement of its three lead and groundbreaking product candidates that have each been proven to be effective in animal models of human CVD: products delivered in drug-eluting stents for coronary and peripheral artery disease, consisting of RNA silencing technology, the lead candidate targeting the blood vessel and clotting regulator plasminogen activator inhibitor type I ( PAI-1 ) Each of the Company's lead products and underlying proprietary technology platforms ( which are covered by an extensive patent portfolio ) operates primarily by regulating blood vessel growth. Therefore, these lead product candidates and the related technologies are applicable to a broad range of diseases where new blood vessel growth may be useful, including congestive heart failure, myocardial infarction ( heart attack ), peripheral arterial disease and skin ulcers. The Company's most advanced product is the MPC therapy, which has achieved outstanding results in extensive pre-clinical development in animal models of several cardiovascular diseases, including studies focused on the regeneration and repair of heart muscle and growth of new blood vessels following a heart attack injury. This product represents what Angioblast believes is the world's leading adult stem cell technology, a groundbreaking advancement in stem cell-based clinical treatment, and which is currently being evaluated in a human clinical trials for treatment of heart damage following a heart attack.

RenalytixAI PLC is an artificial intelligence-enabled in vitro diagnostics company based in New York, NY, dedicated to optimizing clinical management of kidney disease. Through its innovative KidneyIntelX platform, the company aims to improve patient outcomes and reduce healthcare costs by transforming risk assessment and clinical management practices for kidney disease. Since its listing on AIM in November 2018, Renalytix has focused on addressing significant unmet needs in healthcare, leading to advancements such as the FDA approval of KidneyIntelX.dkd in June 2023. Recently, the company announced a collaboration with Tempus AI to enhance the availability of its prognostic blood testing for eligible patients across the Tempus US network of healthcare institutions. Generated from the website

The Premium choice for DNA Testing in New York, NY Privacy is Priceless. Our professionals provide the peace of mind you need.As one of New York's most prominent resources for quality and discreet DNA Tests in NYC, New York Paternity Center specializes in accessible DNA Tests at our private office. We also offer in home DNA collections in the greater New York area for those who need the extra privacy and can also arrange hospital visits.​We aren't just another 'clinic'. We understand the nuances of the industry and the associations of getting a paternity test. Because of this, our services are designed to forgo these negative and often untrue stereotypes. We work on each case in an undivided manner with our absolute attention.All DNA appointments must be scheduled in advance and a deposit is required upon booking. We cater to the needs of those who are in need of the utmost privacy and discretion.First-rate Service Second to NoneNothing more, nothing less. We care about discretion. No questions arise, no judgements are made. We provide a professional service where your DNA test can feel private.You Have High Standards, So Do We.Keep yourself and your loved ones information safe. Our friendly and experienced staff will make sure you always feel comfortable and well-informed.All DNA appointments must be scheduled in advance and a deposit is required upon booking. We cater to the needs of those who are in need of the utmost privacy and discretion.Quality Doesn't Compromise.